Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | NAD dependent epimerase/dehydratase, putative | 0.0099 | 0.3179 | 0.2432 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.004 | 0.1029 | 0.1749 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.004 | 0.1029 | 0.1749 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.014 | 0.4643 | 0.7894 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Toxoplasma gondii | ABC1 family protein | 0.0038 | 0.0988 | 0.1836 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.014 | 0.4643 | 0.4878 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.014 | 0.4643 | 0.7894 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0988 | 0.0546 |
Onchocerca volvulus | 0.004 | 0.1029 | 0.0082 | |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0288 | 1 | 0.5 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0174 | 0.5881 | 1 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0038 | 0.0988 | 0.0546 |
Trichomonas vaginalis | glutaminase, putative | 0.0275 | 0.9518 | 0.9466 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.014 | 0.4643 | 0.4878 |
Leishmania major | udp-glc 4-epimerase, putative | 0.0103 | 0.3326 | 1 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0174 | 0.5881 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0988 | 0.0546 |
Mycobacterium ulcerans | glutaminase | 0.0275 | 0.9518 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0141 | 0.4679 | 0.4928 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0177 | 0.5979 | 1 |
Echinococcus multilocularis | RUN | 0.004 | 0.1029 | 0.1749 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.004 | 0.1029 | 0.1749 |
Brugia malayi | beta-lactamase | 0.0038 | 0.0988 | 0.0868 |
Loa Loa (eye worm) | beta-lactamase | 0.0038 | 0.0988 | 0.0546 |
Echinococcus granulosus | RUN | 0.004 | 0.1029 | 0.1749 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.014 | 0.4643 | 0.7894 |
Schistosoma mansoni | UDP-glucose 4-epimerase | 0.0099 | 0.3179 | 0.334 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0988 | 0.0546 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0988 | 0.0546 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.1029 | 0.0592 |
Schistosoma mansoni | rab6-interacting | 0.004 | 0.1029 | 0.1081 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0246 | 0.8478 | 1 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0288 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0495 | 0.034 |
Trypanosoma cruzi | UDP-galactose 4-epimerase | 0.0099 | 0.3179 | 1 |
Echinococcus multilocularis | UDP glucose 4 epimerase | 0.0099 | 0.3179 | 0.5406 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0038 | 0.0988 | 0.1836 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0038 | 0.0988 | 0.1038 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.014 | 0.4643 | 0.4781 |
Brugia malayi | beta-lactamase family protein | 0.0038 | 0.0988 | 0.0868 |
Brugia malayi | hypothetical protein | 0.004 | 0.1029 | 0.0912 |
Schistosoma mansoni | lipoxygenase | 0.0174 | 0.5881 | 0.6179 |
Onchocerca volvulus | 0.004 | 0.1029 | 0.0082 | |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Brugia malayi | N-terminal motif family protein | 0.0177 | 0.5979 | 0.6211 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0988 | 0.0546 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0038 | 0.0988 | 0.1679 |
Trichomonas vaginalis | UDP-glucose 4-epimerase, putative | 0.0099 | 0.3179 | 0.2432 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.014 | 0.4643 | 0.4878 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Toxoplasma gondii | UDP-glucose 4-epimerase | 0.0099 | 0.3179 | 1 |
Schistosoma mansoni | loxhd1 | 0.004 | 0.1029 | 0.1081 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.004 | 0.1029 | 0.1749 |
Plasmodium vivax | hypothetical protein, conserved | 0.0038 | 0.0988 | 0.923 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.004 | 0.1029 | 0.1749 |
Trichomonas vaginalis | NAD dependent epimerase/dehydratase, putative | 0.0099 | 0.3179 | 0.2432 |
Brugia malayi | hypothetical protein | 0.004 | 0.1029 | 0.0912 |
Brugia malayi | glutaminase DH11.1 | 0.0275 | 0.9518 | 1 |
Schistosoma mansoni | polycystin 1-related | 0.004 | 0.1029 | 0.1081 |
Brugia malayi | Doublecortin family protein | 0.004 | 0.1029 | 0.0912 |
Schistosoma mansoni | rab6-interacting | 0.004 | 0.1029 | 0.1081 |
Loa Loa (eye worm) | glutaminase | 0.0275 | 0.9518 | 1 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.1029 | 0.1081 |
Leishmania major | hypothetical protein, conserved | 0.0038 | 0.0988 | 0.1741 |
Plasmodium falciparum | LCCL domain-containing protein | 0.004 | 0.1029 | 1 |
Loa Loa (eye worm) | doublecortin family protein | 0.004 | 0.1029 | 0.0592 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.014 | 0.4643 | 0.4597 |
Trypanosoma brucei | UDP-galactose 4-epimerase | 0.0103 | 0.3326 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0038 | 0.0988 | 0.1741 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.014 | 0.4643 | 0.7894 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0038 | 0.0988 | 0.1836 |
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 0.0988 | 0.0546 |
Trypanosoma cruzi | UDP-galactose 4-epimerase, putative | 0.0099 | 0.3179 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0038 | 0.0988 | 0.0868 |
Loa Loa (eye worm) | glutaminase 2 | 0.0275 | 0.9518 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0177 | 0.5979 | 0.6078 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0038 | 0.0988 | 0.1038 |
Brugia malayi | UDP galactose 4'-epimerase | 0.0099 | 0.3179 | 0.3214 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.1029 | 0.0592 |
Schistosoma mansoni | lipoxygenase | 0.0103 | 0.3305 | 0.3473 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0141 | 0.4679 | 0.4327 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0141 | 0.4679 | 1 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.004 | 0.1029 | 0.1749 |
Echinococcus granulosus | UDP glucose 4 epimerase | 0.0099 | 0.3179 | 0.5406 |
Schistosoma mansoni | glutaminase | 0.0275 | 0.9518 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0288 | 1 | 1 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.004 | 0.1029 | 1 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0038 | 0.0988 | 0.0868 |
Loa Loa (eye worm) | UDP galactose 4'-epimerase | 0.0099 | 0.3179 | 0.2975 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0038 | 0.0988 | 0.1679 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
C20 APD95 (functional) | = 0.4 uM | Concentration required for 20% increase in action potential duration of canine Purkinje fiber (intracellular electrophysiology) in vitro measured at 95% repolarization was reported. Range is between 0.2-0.5 | ChEMBL. | 3572962 |
C20 APD95 (functional) | = 1.9 uM | Concentration required for 20% increase in action potential duration of canine Purkinje fiber (intracellular electrophysiology) in vitro measured at 95% repolarization was reported. Range is between 1.8-2.0 | ChEMBL. | 3572962 |
C20 APD95 (functional) | = 3 uM | Concentration required for 20% increase in action potential duration of canine Purkinje fiber (intracellular electrophysiology) in vitro measured at 95% repolarization was reported. Range is between 1.6-44 | ChEMBL. | 3572962 |
C20 FRP (functional) | = 0.3 uM | Concentration required for 20% increase in the functional refractory period of canine ventricular muscle (extracellular electrophysiology) in vitro was reported. Range is between 0.03-2.1 | ChEMBL. | 3572962 |
C20 FRP (functional) | = 3 uM | Concentration required for 20% increase in the functional refractory period of canine ventricular muscle (extracellular electrophysiology) in vitro was reported. Range is between 1.2-150 | ChEMBL. | 3572962 |
C20 FRP (functional) | = 40 uM | Concentration required for 20% increase in the functional refractory period of canine ventricular muscle (extracellular electrophysiology) in vitro was reported | ChEMBL. | 3572962 |
Efficacy (functional) | = 3 | Efficacy in blocking sustained ventricular tachycardia (rate>250 bpm) elicited by programmed electrical stimulation in anesthetized dogs after iv administration of 1.4 mg/kg; no. of successful exp / total no. of exp = 3/6 | ChEMBL. | 3572962 |
Efficacy (functional) | = 3 | Efficacy in blocking sustained ventricular tachycardia (rate>250 bpm) elicited by programmed electrical stimulation in anesthetized dogs after iv administration of dose 1.0 mg/kg; no. of successful exp / total no. of exp = 3/4 | ChEMBL. | 3572962 |
Efficacy (functional) | = 4 | Efficacy in blocking sustained ventricular tachycardia (rate>250 bpm) elicited by programmed electrical stimulation in conscious dogs after iv administration of dose 0.5 mg/kg; no. of successful exp / total no. of exp = 4/4 | ChEMBL. | 3572962 |
Efficacy (functional) | = 4 | Efficacy in blocking sustained ventricular tachycardia (rate>250 bpm) elicited by programmed electrical stimulation in anesthetized dogs after iv administration of 0.5 mg/kg; no. of successful exp / total no. of exp = 4/4 | ChEMBL. | 3572962 |
Efficacy (functional) | = 5 | Efficacy in blocking sustained ventricular tachycardia (rate>250 bpm) elicited by programmed electrical stimulation in conscious dogs after iv administration of 1.9 mg/kg; no. of successful exp / total no. of exp = 5/6 | ChEMBL. | 3572962 |
Efficacy (functional) | = 5 | Efficacy in blocking sustained ventricular tachycardia (rate>250 bpm) elicited by programmed electrical stimulation in conscious dogs after iv administration of 0.8 mg/kg; no. of successful exp / total no. of exp = 5/5 | ChEMBL. | 3572962 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.